These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 6849138)
1. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Schwarcz R; Whetsell WO; Mangano RM Science; 1983 Jan; 219(4582):316-8. PubMed ID: 6849138 [TBL] [Abstract][Full Text] [Related]
2. Differential vulnerability of central neurons of the rat to quinolinic acid. Schwarcz R; Köhler C Neurosci Lett; 1983 Jul; 38(1):85-90. PubMed ID: 6225037 [TBL] [Abstract][Full Text] [Related]
3. Excitotoxic models for neurodegenerative disorders. Schwarcz R; Foster AC; French ED; Whetsell WO; Köhler C Life Sci; 1984 Jul; 35(1):19-32. PubMed ID: 6234446 [TBL] [Abstract][Full Text] [Related]
4. The neurotoxic actions of quinolinic acid in the central nervous system. el-Defrawy SR; Boegman RJ; Jhamandas K; Beninger RJ Can J Physiol Pharmacol; 1986 Mar; 64(3):369-75. PubMed ID: 2939936 [TBL] [Abstract][Full Text] [Related]
5. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Foster AC; Collins JF; Schwarcz R Neuropharmacology; 1983 Dec; 22(12A):1331-42. PubMed ID: 6229703 [TBL] [Abstract][Full Text] [Related]
6. Sparing of cholinergic neurons following quinolinic acid lesions of the rat striatum. Davies SW; Roberts PJ Neuroscience; 1988 Aug; 26(2):387-93. PubMed ID: 2971892 [TBL] [Abstract][Full Text] [Related]
7. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB Synapse; 1989; 3(1):38-47. PubMed ID: 2563916 [TBL] [Abstract][Full Text] [Related]
8. Effects of intracerebral injections of quinolinic acid on serotonergic neurons in the rat brain. Aldinio C; Mazzari S; Toffano G; Köhler C; Schwarcz R Brain Res; 1985 Aug; 341(1):57-65. PubMed ID: 2412634 [TBL] [Abstract][Full Text] [Related]
10. Dissociation between the excitatory and "excitotoxic" effects of quinolinic acid analogs on the striatal cholinergic interneuron. Lehmann J; Ferkany JW; Schaeffer P; Coyle JT J Pharmacol Exp Ther; 1985 Mar; 232(3):873-82. PubMed ID: 2983071 [TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins. Waldvogel HJ; Faull RL; Williams MN; Dragunow M Brain Res; 1991 Apr; 546(2):329-35. PubMed ID: 1829975 [TBL] [Abstract][Full Text] [Related]
12. The effect of kainic, quinolinic and beta-kainic acids on the release of endogenous amino acids from rat brain slices. Connick JH; Stone TW Biochem Pharmacol; 1986 Oct; 35(20):3631-5. PubMed ID: 2876711 [TBL] [Abstract][Full Text] [Related]
13. Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes. Björklund H; Olson L; Dahl D; Schwarcz R Brain Res; 1986 Apr; 371(2):267-77. PubMed ID: 2938667 [TBL] [Abstract][Full Text] [Related]
14. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Foster AC; Vezzani A; French ED; Schwarcz R Neurosci Lett; 1984 Aug; 48(3):273-8. PubMed ID: 6237279 [TBL] [Abstract][Full Text] [Related]
15. Quinolinic acid, an endogenous metabolite with neurotoxic properties, alters the physical state of membrane proteins in human erythrocytes. Farmer BT; Butterfield DA Life Sci; 1984 Jul; 35(5):501-9. PubMed ID: 6087067 [TBL] [Abstract][Full Text] [Related]
16. [Morphological picture of lesions to substantia nigra of rats following intracardial administration of quinolinic acid]. Markiewicz D; Beskid M Pol Tyg Lek; 1989 Apr; 44(10-11):262-4. PubMed ID: 2530499 [TBL] [Abstract][Full Text] [Related]
17. In vivo brain dialysis of amino acids and simultaneous EEG measurements following intrahippocampal quinolinic acid injection: evidence for a dissociation between neurochemical changes and seizures. Vezzani A; Ungerstedt U; French ED; Schwarcz R J Neurochem; 1985 Aug; 45(2):335-44. PubMed ID: 3159848 [TBL] [Abstract][Full Text] [Related]
18. Quinolinic and kainic acids can enhance calcitonin gene-related peptide-like immunoreactivity in striatal neurons with substance P-like immunoreactivity. Sugimoto T; Mizuno N Brain Res; 1987 Aug; 418(2):392-7. PubMed ID: 2445418 [TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity of neuropeptide Y, somatostatin and NADPH-diaphorase containing neurons in rat cortex and striatum to quinolinic acid. Boegman RJ; Parent A Brain Res; 1988 Apr; 445(2):358-62. PubMed ID: 2897226 [TBL] [Abstract][Full Text] [Related]
20. Localization of immunoreactive GABA and enkephalin and NADPH-diaphorase-positive neurons in fetal striatal grafts in the quinolinic-acid-lesioned rat neostriatum. Roberts RC; Difiglia M J Comp Neurol; 1988 Aug; 274(3):406-21. PubMed ID: 2975675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]